• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
The European Automobile Manufacturers Association (EADA) reported that electric vehicles accounted for 67.8% of all new car registrations in the EU, UK, and EFTA countries in June.July 23 - According to Alibaba Cloud, the Alibaba Zhenwu M890 supernode has been successfully adapted to Qwen3.8 and launched on the Alibaba Cloud Bailian platform to provide model inference services, becoming the first supernode in China to successfully run a large model with over 2 trillion parameters.On July 23, the General Office of the Sichuan Provincial Peoples Government recently issued the "Work Plan for Sichuan Province to Vigorously Promote the Large-Scale Development and Application of New Energy Freight Vehicles." The plan proposes to strive for policy support for large-scale equipment replacement. It aims to make good use of large-scale equipment replacement policies, actively seek national ultra-long-term special treasury bond funds, and support the scrapping and replacement of old operating freight vehicles that meet the scope of national large-scale equipment replacement policy support with new energy freight vehicles. It also supports the purchase of new energy urban cold chain delivery freight vehicles, striving to have more than 40,000 new energy freight vehicles by the end of 2027.Shares of Alphabet, Googles parent company, fell 3% on the Frankfurt Stock Exchange after the company released its earnings report and capital expenditure plans.Teslas shares, listed in Frankfurt, fell nearly 5% after earnings missed expectations.

Goldman Sachs Has Improved Humana's Competitive Standing

Aria Thomas

Dec 14, 2022 10:41

2.png


Goldman Sachs analysts upgraded shares of Humana (NYSE:HUM) to Buy with a $652 price target in a research note published on Tuesday.


The company's improved "competitive positioning in MA and underappreciated HC Services opportunity should outweigh the potential RADV impact," which Goldman Sachs estimates to range between $2.6 and $5.8 billion (NPV) before offsetting factors.


Analysts stated, "We see a strengthening earnings outlook as a result of improved competitive positioning in Massachusetts, which has reaccelerated member growth for 2023 and could lead to multiple years of share gains in 2024 when many competitors will face Stars headwinds." "We also see an attractive and undervalued opportunity in the health care services sector, with primary care earnings having the potential to outperform its September guidance,"


While analysts assert that the company is aware of the significant risk posed by the forthcoming RADV ruling, their EPS estimates for 2024-2025 are 4% higher than the industry average.


This reflects "3% higher member growth and a primary care EBITDA opportunity of $205mn-$395mn for 2025," which is "above the company's $100-$200mn outlook in its mid-term guidance, with more of this EBITDA hitting the P&L as WCAS centers come onto the balance sheet."


"Despite the stock's outperformance in 2022 (+18% YTD vs. MCO group +13%), the stock trades in line with its historical median despite higher forward EPS CAGR of 15% vs. its 3-year history of 12%," concluded the analysts.